Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:19
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
Edmunds: The best three-row SUVs of 2023
Tupperware may not go out of business after all
Foxconn shares drop after report of China tax audit, land use probe
monday.com Announces Appointment of General Manager of APJ and Hybrid Regional Structure
Japan's cabinet to approve economic package on Nov 2
SSR Mining Reports Third Quarter 2023 Results
EXERTIS Scales With Boomi, Increasing Partner and Customer Satisfaction Globally
ECB to raise rates by 25 basis points in July, slim majority say Sept too